ZOETIS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.8 USD | -0.30% |
|
+0.19% | -13.04% |
| May. 29 | Transcript : Zoetis Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 12:05 PM | |
| May. 23 | Declaration of Voting Results by Zoetis Inc | CI |
ETFs positioned on Zoetis Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 23 M€ | -.--% | - | |
| 0.20% | 7 M€ | +5.16% | - | |
| 0.20% | 32 M€ | +0.57% | - | |
| 0.20% | 17 M€ | +5.16% | - | |
| 0.20% | 57 M€ | +21.87% | - | |
| 0.19% | 4 M€ | -.--% | - | |
| 0.18% | 14 M€ | +16.19% | - | |
| 0.17% | 283 M€ | +20.53% | ||
| 0.17% | 1 M€ | +3.03% | - | |
| 0.15% | 1,166 M€ | +0.26% | - | |
| 0.15% | 607 M€ | +0.05% | - | |
| 0.14% | 205 M€ | -.--% | ||
| 0.13% | 571 M€ | +7.38% | - | |
| 0.13% | 20 M€ | +1.08% | - | |
| 0.13% | 0 M€ | 0.00% | - | |
| 0.11% | 34 M€ | +8.31% | - | |
| 0.11% | 9 M€ | +9.17% | ||
| 0.11% | 9 M€ | +9.67% | - | |
| 0.10% | 391 M€ | +8.46% | - | |
| 0.09% | 15 M€ | -1.62% | - | |
| 0.08% | 306 M€ | +5.68% | - | |
| 0.08% | 39 M€ | +6.05% | - | |
| 0.06% | 17 M€ | +2.99% | - | |
| 0.06% | 17 M€ | +3.75% | - |
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
172.4
USD
Average target price
211.2
USD
Spread / Average Target
+22.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.04% | 78.65B | |
| +21.17% | 8.77B | |
| +25.50% | 3.68B | |
| -2.50% | 3.21B | |
| +12.67% | 1.77B | |
| -25.16% | 1.24B | |
| -27.23% | 1.2B | |
| -18.50% | 1.05B | |
| -7.57% | 951M | |
| -2.72% | 901M |
- Stock Market
- Equities
- ZTS Stock
- Funds and ETFs Zoetis Inc.
